KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GSK) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to $966.9 million.

  • Gsk's Profit After Tax fell 6841.27% to $966.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.3 billion, marking a year-over-year increase of 3446.74%. This contributed to the annual value of $8.3 billion for FY2025, which is 11985.91% up from last year.
  • Latest data reveals that Gsk reported Profit After Tax of $966.9 million as of Q4 2025, which was down 6841.27% from $2.9 billion recorded in Q3 2025.
  • In the past 5 years, Gsk's Profit After Tax ranged from a high of $4.3 billion in Q4 2022 and a low of $84.5 million during Q3 2024
  • Its 5-year average for Profit After Tax is $2.2 billion, with a median of $2.1 billion in 2021.
  • As far as peak fluctuations go, Gsk's Profit After Tax plummeted by 9674.45% in 2024, and later soared by 332475.32% in 2025.
  • Quarter analysis of 5 years shows Gsk's Profit After Tax stood at $1.3 billion in 2021, then surged by 245.9% to $4.3 billion in 2022, then fell by 3.37% to $4.2 billion in 2023, then dropped by 26.94% to $3.1 billion in 2024, then plummeted by 68.41% to $966.9 million in 2025.
  • Its Profit After Tax was $966.9 million in Q4 2025, compared to $2.9 billion in Q3 2025 and $2.2 billion in Q2 2025.